Gene therapy for hemophilia represents a revolutionary advancement in medical science, offering new hope to patients suffering from this hereditary bleeding disorder.With promising treatments like Hemgenix, approved in 2022, individuals with hemophilia B can now experience fewer complications and improved quality of life.